Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results

Published 01/04/2024, 18:47
Updated 01/04/2024, 20:10
© Reuters.  Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower midway through trading, with the Dow Jones falling over 300 points on Monday.

The Dow traded down 0.79% to 39,492.80 while the NASDAQ fell 0.22% to 16,344.11. The S&P 500 also fell, dropping, 0.45% to 5,230.46.

Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'

Leading and Lagging Sectors

Communication services shares jumped by 1.1% on Monday.

In trading on Monday, real estate shares fell by 1.8%.

Top Headline

Shares of Oxford Industries, Inc. (NYSE: OXM) fell more than 4% on Monday after the company reported downbeat financial results for its fourth quarter and issued weak guidance for the first quarter on Thursday.

Equities Trading UP

CXApp Inc. (NASDAQ: CXAI) shares shot up 143% to $5.95 after the company announced a partnership with Google Cloud for acceleration of the CXAI platform.

Shares of Sunshine Biopharma, Inc. (NASDAQ: SBFM) got a boost, surging 87% to $0.1138 after the company FY23 operating results.

Doma Holdings Inc. (NYSE: DOMA) shares were also up, gaining 34% to $6.07 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.

Equities Trading DOWN

Nuvve Holding Corp. (NASDAQ: NVVE) shares dropped 29% to $0.7798 after the company reported worse-than-expected fourth-quarter financial results.

Shares of AEON Biopharma, Inc. (NYSE: AEON) were down 41% to $6.86 after the company reported a fourth-quarter loss of 71 cents per share.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Disc Medicine, Inc. (NASDAQ: IRON) was down, falling 50% to $31.25 after the company reported topline results from the Phase 2 AURORA study of bitopertin in patients with EPP.

Also Check This Out: Bitcoin Trades Above $70,000 Following GDP, Jobless Claims Data; GateToken Emerges As Top Gainer

Commodities

In commodity news, oil traded up 0.9% to $83.92 while gold traded up 0.9% at $2,259.20.

Silver traded up 0.8% to $25.12 on Monday, while copper rose 1% to $4.0475.

Economics

The ISM Manufacturing PMI rose to 50.3 in March versus 47.8 in February and topping market estimates of 48.4.

U.S. construction spending fell by 0.3% from the prior month in February.

The S&P Global manufacturing PMI was revised lower to 51.9 in March compared to a preliminary reading of 52.5.

Now Read This: $5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.